Michael Rapp, Director at Immunome Inc. (IMNM), bought 76,400 shares at $18.46 ($1.4M) on 2021-09-09, disclosed to the SEC on 2021-09-13.
Open-market purchase of $1.4M IMNM by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.44 | 8,170 | $142K | 10.3% |
| 2 | $17.44 | 8,170 | $142K | 10.3% |
| 3 | $18.46 | 22,280 | $411K | 29.7% |
| 4 | $18.46 | 22,280 | $411K | 29.7% |
| 5 | $17.85 | 15,500 | $277K | 20.0% |
| Total | $18.12 avg | 76,400 |
| $1.4M |
| 100% |
| Filing → |
| IMNM | BUY | 2020-10-08 | $1000K | — | Filing → |
| ZYNE | BUY | 2018-05-31 | $123K | — | Filing → |
| ZYNE | BUY | 2018-05-02 | $157K | — | Filing → |